510(k) Report

FDA applicant

Terumo Europe N.V.

Leuven, BE28 decisions1999–20251 recall

FDA records 28 decisions for Terumo Europe N.V. (Leuven, BE) from 1999 to 2025: 28 510(k) clearances. Most are in product codes FMI (Needle, Hypodermic, Single Lumen) and FPA (Set, Administration, Intravascular). Since 2016 its 510(k)s took a median of 181 days from receipt to decision, against 141 for FDA’s reviews in the same codes and years. Its devices cite 50 predicates, 32 of them its own earlier devices. 1 recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, general hospital panel, where it files most

How often FDA has decided Terumo Europe N.V.’s devices, and how often a recall has named them.

FDA decisions per year

3in 2025

2007: 42008: 12009: 12010: 12011: 32013: 12014: 22015: 22017: 12019: 12022: 12023: 12025: 3
2007high 4 (2007) · low 0 (2012)2026

2026 so far, outlined.

Recalls per year

1in 2015

2015: 1
2007high 1 (2015) · low 0 (2007)2026

Class I Class II/III not classified

FIG. 1 — Terumo Europe N.V. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Terumo Europe N.V.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Terumo”

FDA records each applicant name separately; these may or may not be the same firm.